NA Epilepsy Monitoring Devices Market - Industry Trends and Forecast to 2030

Description

List of Tables

North America epilepsy monitoring devices market is projected to register a substantial CAGR of 5.8% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

By Product Type (Wearable Devices, Smart Devices, and Conventional Devices), By Type (Generalized Seizures, and Focal Seizure), By Patient Type (Pediatric, Adult, and Geriatric), By End User (Hospitals, Ambulatory Surgical Centres and Clinics, Neurological Centres, Diagnostic Centres, Homecare, and Others), By Distribution Channel (Direct Tender, Retail Sales, Online Sales, and Others), By Countries (U.S., Canada, Mexico,). Industry Trends & Forecast to 2030

Some of the major factors contributing to the growth of the North America epilepsy monitoring devices market are:

Rising prevalence of epilepsy

Growing preference for wearable epilepsy monitoring devices

Rising government investments in the epilepsy project

Increased r & d activities in epilepsy

Market Players

Some of the key market players for the North America epilepsy monitoring devices market are listed below:

Apple Inc.

NIHON KOHDEN CORPORATION.

Natus Medical Incorporated.

Owlet

Masimo

Neurotech, LLC

Others

1 INTRODUCTION 69

1.1 OBJECTIVES OF THE STUDY 69
1.2 MARKET DEFINITION 69
1.3 OVERVIEW OF THE NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET 69
1.4 CURRENCY AND PRICING 71
1.5 LIMITATIONS 71
1.6 MARKETS COVERED 72

2 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION 75

2.1 MARKETS COVERED 75
2.2 GEOGRAPHICAL SCOPE 76
2.3 YEARS CONSIDERED FOR THE STUDY 77
2.4 DBMR TRIPOD DATA VALIDATION MODEL 78
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 81
2.6 MULTIVARIATE MODELLING 82
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 83
2.8 DBMR MARKET POSITION GRID 84
2.9 VENDOR SHARE ANALYSIS 86
2.10 MARKET END USER COVERAGE GRID 87
2.11 SECONDARY SOURCES 88

3 EXECUTIVE SUMMARY 89

4 PREMIUM INSIGHTS 91

4.1 PREMIUM INSIGHTS 92
- 4.1.1 KEY STRATEGIC INITIATIVES 92
- 4.1.2 SEIZURES OCCURRENCE, BY TIME 93
  - 4.1.2.1 DURING DAY 93
  - 4.1.2.2 DURING SLEEP 94
    - 4.1.2.2.1 RAPID EYE MOVEMENT (REM) SLEEP 94
    - 4.1.2.2.2 NON-REM SLEEP 94
  - 4.1.2.3 DURING NIGHT 94

5 EPIDEMIOLOGY 95

5.1 INCIDENCE & PREVALENCE OF EPILEPSY, BY COUNTRY 95
- 5.1.1 GENERALIZED SEIZURES, BY PATIENT TYPE 96
  - 5.1.1.1 TONIC-CLONIC SEIZURES 96
  - 5.1.1.2 ABSENCE SEIZURES 96
- 5.1.2 FOCAL SEIZURES, BY PATIENT TYPE 97
  - 5.1.2.1 SIMPLE FOCAL SEIZURES 97
  - 5.1.2.2 COMPLEX FOCAL SEIZURES 97
  - 5.1.2.3 SECONDARY GENERALIZED SEIZURES 97

6 NORTH AMERICA EPILEPSY MONITORING DEVICE MARKET, REGULATORY FRAMEWORK 98

6.1 MEDICAL DEVICES 98
6.2 WEARABLE MEDICAL DEVICES 101

7 MARKET OVERVIEW 106

7.1 DRIVERS 108
- 7.1.1 RISING PREVALENCE OF EPILEPSY 108
- 7.1.2 GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES 108
- 7.1.3 RISING GOVERNMENT INVESTMENTS IN THE EPILEPSY PROJECT 109
- 7.1.4 INCREASED R & D ACTIVITIES IN EPILEPSY 109
7.2 RESTRAINTS 110
- 7.2.1 HIGH COST ASSOCIATED WITH COMPLEX EPILEPSY MONITORING PROCEDURES & DEVICES 110
- 7.2.2 PRODUCT RECALL SCENARIO OF EPILEPSY MONITORING DEVICES 110
7.3 OPPORTUNITIES 111
- 7.3.1 RISE IN TECHNOLOGY ADVANCEMENT IN DISEASE MONITORING DEVICE 111
- 7.3.2 INCREASED DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE DEVICE 111
7.4 CHALLENGES 112
- 7.4.1 POOR REIMBURSEMENT SCENARIO 112
- 7.4.2 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL 112

8 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE 113

8.1 OVERVIEW 114
8.2 WEARABLE DEVICES 117
- 8.2.1 SMART WATCHES 118
- 8.2.2 OTHER NON-INVASIVE MONITORING DEVICES 118
8.3 SMART DEVICES 118
- 8.3.1 MOTION MONITORS 119
- 8.3.2 1.3.2 VIDEO MONITORS 119
- 8.3.3 MATTRESS DEVICES 119
- 8.3.4 OTHERS 120
8.4 CONVENTIONAL DEVICES 120
- 8.4.1 EEG DEVICE 121
  - 8.4.1.1 AMBULATORY EEG 121
  - 8.4.1.2 CONTINUOUS EEG 121
  - 8.4.1.3 OTHER EEG DEVICES 122
- 8.4.2 ELECTROMYOGRAPHY (EMG) DEVICE 122
- 8.4.3 ELECTROCARDIOGRAM (ECG) DEVICE 122
- 8.4.4 PULSE- OXIMETERS 122
- 8.4.5 IMPLANTED ADVISORY SYSTEM 122
- 8.4.6 TRIAXIAL ACCELEROMETER (ACM) 122
- 8.4.7 MAGNETOMETERS 122
- 8.4.8 OTHER DEVICES 122

9 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE 123

9.1 OVERVIEW 124
9.2 FOCAL SEIZURES 127
- 9.2.1 SIMPLE FOCAL SEIZURES 128
  - 9.2.1.1 SMART DEVICES 128
  - 9.2.1.2 WEARABLE DEVICES 128
  - 9.2.1.3 CONVENTIONAL DEVICES 128
- 9.2.2 COMPLEX FOCAL SEIZURES 129
  - 9.2.2.1 SMART DEVICES 129
  - 9.2.2.2 WEARABLE DEVICES 129
  - 9.2.2.3 CONVENTIONAL DEVICES 129
- 9.2.3 SECONDARY GENERALIZED SEIZURES 129
  - 9.2.3.1 SMART DEVICES 130
  - 9.2.3.2 WEARABLE DEVICES 130
  - 9.2.3.3 CONVENTIONAL DEVICES 130
9.3 GENERALIZED SEIZURES 130
- 9.3.1 TONIC-CLONIC SEIZURES 131
  - 9.3.1.1 SMART DEVICES 132
  - 9.3.1.2 WEARABLE DEVICES 132
  - 9.3.1.3 CONVENTIONAL DEVICES 132
- 9.3.2 ABSENCE SEIZURES 132
  - 9.3.2.1 SMART DEVICES 132
  - 9.3.2.2 WEARABLE DEVICES 132
  - 9.3.2.3 CONVENTIONAL DEVICES 133

10 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE 134

10.1 OVERVIEW 135
10.2 PEDIATRIC 138
10.3 GERIATRIC 138
10.4 ADULTS 139

11 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY END USER 140

11.1 OVERVIEW 141
11.2 HOSPITALS 144
11.3 HOMECARE SETTINGS 144
11.4 NEUROLOGY CENTRES 145
11.5 DIAGNOSTIC CENTRES 145
11.6 AMBULATORY SURGICAL CENTRES AND CLINICS 146
11.7 OTHERS 147

12 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL 148

12.1 OVERVIEW 149
12.2 RETAIL SALES 152
12.3 ONLINE SALES 152
12.4 DIRECT TENDERS 153
12.5 OTHERS 153

13 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY REGION 155

13.1 NORTH AMERICA 156
- 13.1.1 U.S. 167
- 13.1.2 CANADA 174
- 13.1.3 MEXICO 180

14 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: COMPANY LANDSCAPE 186

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 186

15 SWOT 187

16 COMPANY PROFILES 188

16.1 NIHON KOHDEN CORPORATION. 188
- 16.1.1 COMPANY SNAPSHOT 188
- 16.1.2 RECENT FINANCIALS 188
- 16.1.3 COMPANY SHARE ANALYSIS 189
- 16.1.4 PRODUCT PORTFOLIO 189
- 16.1.5 RECENT DEVELOPMENT 189
16.2 MASIMO 190
- 16.2.1 COMPANY SNAPSHOT 190
- 16.2.2 RECENT FINANCIALS 190
- 16.2.3 COMPANY SHARE ANALYSIS 191
- 16.2.4 PRODUCT PORTFOLIO 191
- 16.2.5 RECENT DEVELOPMENT 191
16.3 APPLE INC. 193
- 16.3.1 COMPANY SNAPSHOT 193
- 16.3.2 REVENUE ANALYSIS 193
- 16.3.3 COMPANY SHARE ANALYSIS 194
- 16.3.4 PRODUCT PORTFOLIO 194
- 16.3.5 RECENT DEVELOPMENTS 194
16.4 NATUS MEDICAL INCORPORATED. 195
- 16.4.1 COMPANY SNAPSHOT 195
- 16.4.2 RECENT FINANCIALS 195
- 16.4.3 COMPANY SHARE ANALYSIS 197
- 16.4.4 PRODUCT PORTFOLIO 197
- 16.4.5 RECENT DEVELOPMENT 198
16.5 OWLET. 199
- 16.5.1 COMPANY SNAPSHOT 199
- 16.5.2 REVENUE ANALYSIS 199
- 16.5.3 COMPANY SHARE ANALYSIS 200
- 16.5.4 PRODUCT PORTFOLIO 200
- 16.5.5 RECENT DEVELOPMENT 200
16.6 ACTIGRAPH, LLC. 202
- 16.6.1 COMPANY SNAPSHOT 202
- 16.6.2 PRODUCT PORTFOLIO 202
- 16.6.3 RECENT DEVELOPMENT 202
16.7 ADVANCED BRAIN MONITORING, INC. 204
- 16.7.1 COMPANY SNAPSHOT 204
- 16.7.2 PRODUCT PORTFOLIO 204
- 16.7.3 RECENT DEVELOPMENT 206
16.8 CAPTUREPROFF INC. 206
- 16.8.1 COMPANY SNAPSHOT 206
- 16.8.2 PRODUCT PORTFOLIO 206
- 16.8.3 RECENT DEVELOPMENT 207
16.9 EMPATICA INC. 207
- 16.9.1 COMPANY SNAPSHOT 207
- 16.9.2 PRODUCT PORTFOLIO 207
- 16.9.3 RECENT DEVELOPMENT 207
16.10 EPIHUNTER 208
- 16.10.1 COMPANY SNAPSHOT 208
- 16.10.2 PRODUCT PORTFOLIO 208
- 16.10.3 RECENT DEVELOPMENT 209
16.11 EPILERT 209
- 16.11.1 COMPANY SNAPSHOT 209
- 16.11.2 PRODUCT PORTFOLIO 209
- 16.11.3 RECENT DEVELOPMENT 210
16.12 EPILEPSY ALARMS UK 211
- 16.12.1 COMPANY SNAPSHOT 211
- 16.12.2 PRODUCT PORTFOLIO 211
- 16.12.3 RECENT DEVELOPMENT 212
16.13 EPI USA. 212
- 16.13.1 COMPANY SNAPSHOT 212
- 16.13.2 PRODUCT PORTFOLIO 212
- 16.13.3 RECENT DEVELOPMENT 212
16.14 EPIVIEW 213
- 16.14.1 COMPANY SNAPSHOT 213
- 16.14.2 PRODUCT PORTFOLIO 213
- 16.14.3 RECENT DEVELOPMENT 213
16.15 FREQUENCY PRECISION. 214
- 16.15.1 COMPANY SNAPSHOT 214
- 16.15.2 PRODUCT PORTFOLIO 214
- 16.15.3 RECENT DEVELOPMENT 214
16.16 HIPASS DESIGN LLC 215
- 16.16.1 COMPANY SNAPSHOT 215
- 16.16.2 PRODUCT PORTFOLIO 215
- 16.16.3 RECENT DEVELOPMENT 215
16.17 IBABY LABS, INC. 216
- 16.17.1 COMPANY SNAPSHOT 216
- 16.17.2 PRODUCT PORTFOLIO 216
- 16.17.3 RECENT DEVELOPMENT 216
16.18 ITS DESIGNS LTD 217
- 16.18.1 COMPANY SNAPSHOT 217
- 16.18.2 PRODUCT PORTFOLIO 217
- 16.18.3 RECENT DEVELOPMENT 217
16.19 LIVASSURED 218
- 16.19.1 COMPANY SNAPSHOT 218
- 16.19.2 PRODUCT PORTFOLIO 218
- 16.19.3 RECENT DEVELOPMENT 218
16.20 LIVELIFE ALARMS. 218
- 16.20.1 COMPANY SNAPSHOT 218
- 16.20.2 PRODUCT PORTFOLIO 219
- 16.20.3 RECENT DEVELOPMENT 219
16.21 MEDPAGE LTD 220
- 16.21.1 COMPANY SNAPSHOT 220
- 16.21.2 PRODUCT PORTFOLIO 220
- 16.21.3 RECENT DEVELOPMENT 221
16.22 MIKU INC. 221
- 16.22.1 COMPANY SNAPSHOT 221
- 16.22.2 PRODUCT PORTFOLIO 221
- 16.22.3 RECENT DEVELOPMENT 221
16.23 NEUROSOFT 222
- 16.23.1 COMPANY SNAPSHOT 222
- 16.23.2 PRODUCT PORTFOLIO 222
- 16.23.3 RECENT DEVELOPMENTS 223
16.24 NEUROTECH, LLC 224
- 16.24.1 COMPANY SNAPSHOT 224
- 16.24.2 PRODUCT PORTFOLIO 224
- 16.24.3 RECENT DEVELOPMENT 224
16.25 SAFE-LIFE 225
- 16.25.1 COMPANY SNAPSHOT 225
- 16.25.2 PRODUCT PORTFOLIO 225
- 16.25.3 RECENT DEVELOPMENT 225
16.26 SMARTMONITOR 226
- 16.26.1 COMPANY SNAPSHOT 226
- 16.26.2 PRODUCT PORTFOLIO 226
- 16.26.3 RECENT DEVELOPMENT 226
16.27 SNUZA 227
- 16.27.1 COMPANY SNAPSHOT 227
- 16.27.2 PRODUCT PORTFOLIO 227
- 16.27.3 RECENT DEVELOPMENT 227

16.28 THE 'LIFE MINDER' 228
- 16.28.1 COMPANY SNAPSHOT 228
- 16.28.2 PRODUCT PORTFOLIO 228
- 16.28.3 RECENT DEVELOPMENT 228
16.29 VAHLKAMP INTERNATIONAL B.V. 229
- 16.29.1 COMPANY SNAPSHOT 229
- 16.29.2 PRODUCT PORTFOLIO 229
- 16.29.3 RECENT DEVELOPMENT 229

17 QUESTIONNAIRE 230

18 RELATED REPORTS 233

LIST OF TABLES

TABLE 1 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS) 52
TABLE 2 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS) 53
TABLE 3 REGULATORY APPROVAL CONSIDERATIONS IN WEARABLE MEDICAL DEVICES (WMDS) 55
TABLE 4 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
TABLE 5 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 68
TABLE 6 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 69
TABLE 7 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 70
TABLE 8 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 70
TABLE 9 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 71
TABLE 10 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
TABLE 11 NORTH AMERICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 72
TABLE 12 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 77
TABLE 13 NORTH AMERICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 14 NORTH AMERICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 79
TABLE 15 NORTH AMERICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 79
TABLE 16 NORTH AMERICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 80
TABLE 17 NORTH AMERICA SECONDARY GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 81
TABLE 18 NORTH AMERICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 82
TABLE 19 NORTH AMERICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 82
TABLE 20 NORTH AMERICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION)) 82
TABLE 21 NORTH AMERICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 83
TABLE 22 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 88
TABLE 23 NORTH AMERICA PEDIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 24 NORTH AMERICA GERIATRIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 25 NORTH AMERICA ADULTS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 26 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 94
TABLE 27 NORTH AMERICA HOSPITALS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 28 NORTH AMERICA HOMECARE SETTINGS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 29 NORTH AMERICA NEUROLOGY CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 30 NORTH AMERICA DIAGNOSTIC CENTERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 97
TABLE 31 NORTH AMERICA AMBULATORY SURGICAL CENTRES AND CLINIC IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 32 NORTH AMERICA OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 33 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 102
TABLE 34 NORTH AMERICA RETAIL SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 35 NORTH AMERICA ONLINE SALES IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 36 NORTH AMERICA DIRECT TENDERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 104
TABLE 37 NORTH AMERICA OTHERS IN EPILEPSY MONITORING DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION) 105
TABLE 38 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 111
TABLE 39 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 40 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 111
TABLE 41 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 111
TABLE 42 NORTH AMERICA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 112
TABLE 43 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
TABLE 44 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 112
TABLE 45 NORTH AMERICA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 112
TABLE 46 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
TABLE 47 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 113
TABLE 48 NORTH AMERICA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 114
TABLE 49 NORTH AMERICA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
TABLE 50 NORTH AMERICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 114
TABLE 51 NORTH AMERICA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 114
TABLE 52 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 115
TABLE 53 NORTH AMERICA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 115
TABLE 54 NORTH AMERICA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 115
TABLE 55 NORTH AMERICA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 115
TABLE 56 NORTH AMERICA SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 116
TABLE 57 NORTH AMERICA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 116
TABLE 58 NORTH AMERICA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 116
TABLE 59 NORTH AMERICA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 116
TABLE 60 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 117
TABLE 61 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 117
TABLE 62 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 117
TABLE 63 U.S. EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
TABLE 64 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 118
TABLE 65 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 118
TABLE 66 U.S. WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 118
TABLE 67 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 119
TABLE 68 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 119
TABLE 69 U.S. SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 119
TABLE 70 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
TABLE 71 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 120
TABLE 72 U.S. CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 121
TABLE 73 U.S. EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
TABLE 74 U.S. EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 121
TABLE 75 U.S. EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 121
TABLE 76 U.S. EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
TABLE 77 U.S. FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
TABLE 78 U.S. SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
TABLE 79 U.S. COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 122
TABLE 80 U.S. SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 123
TABLE 81 U.S. GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 123
TABLE 82 U.S. TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 123
TABLE 83 U.S. ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 123
TABLE 84 U.S. EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 124
TABLE 85 U.S. EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 124
TABLE 86 U.S. EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 124
TABLE 87 CANADA EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 88 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
TABLE 89 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 125
TABLE 90 CANADA WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 125
TABLE 91 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 92 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 126
TABLE 93 CANADA SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 126
TABLE 94 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
TABLE 95 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 127
TABLE 96 CANADA CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 127
TABLE 97 CANADA EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 127
TABLE 98 CANADA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 128
TABLE 99 CANADA EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 128
TABLE 100 CANADA EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 128
TABLE 101 CANADA FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 128
TABLE 102 CANADA SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 128
TABLE 103 CANADA COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 129
TABLE 104 CANADA SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 129
TABLE 105 CANADA GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 129
TABLE 106 CANADA TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 129
TABLE 107 CANADA ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 130
TABLE 108 CANADA EPILEPSY MONITORING DEVICES MARKET, BY PATIENT TYPE, 2021-2030 (USD MILLION) 130
TABLE 109 CANADA EPILEPSY MONITORING DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION) 130
TABLE 110 CANADA EPILEPSY MONITORING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 130
TABLE 111 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 112 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
TABLE 113 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 131
TABLE 114 MEXICO WEARABLE DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 131
TABLE 115 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 116 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 132
TABLE 117 MEXICO SMART DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 132
TABLE 118 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
TABLE 119 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 133
TABLE 120 MEXICO CONVENTIONAL DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 133
TABLE 121 MEXICO EEG DEVICE IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 133
TABLE 122 MEXICO EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (UNIT) 134
TABLE 123 MEXICO EEG DEVICES IN EPILEPSY MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP) 134
TABLE 124 MEXICO EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 134
TABLE 125 MEXICO FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 134
TABLE 126 MEXICO SIMPLE FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 134
TABLE 127 MEXICO COMPLEX FOCAL SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
TABLE 128 MEXICO SECONDARY GENERALISED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
TABLE 129 MEXICO GENERALIZED SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
TABLE 130 MEXICO TONIC-CLONIC SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 135
TABLE 131 MEXICO ABSENCE SEIZURES IN EPILEPSY MONITORING DEVICES MARKET, BY TYPE, 2021-2030 (USD MILLION) 136

LIST OF FIGURES

FIGURE 1 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION 25
FIGURE 2 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: DATA TRIANGULATION 28
FIGURE 3 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: DROC ANALYSIS 29
FIGURE 4 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 30
FIGURE 5 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: COMPANY RESEARCH ANALYSIS 30
FIGURE 6 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: INTERVIEW DEMOGRAPHICS 31
FIGURE 7 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: DBMR POSITION GRID 34
FIGURE 8 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: VENDOR SHARE ANALYSIS 36
FIGURE 9 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: END USER COVERAGE GRID 37
FIGURE 10 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SEGMENTATION 40
FIGURE 11 THE RISING PREVALENCE OF EPILEPSY & GROWING PREFERENCE FOR WEARABLE EPILEPSY MONITORING DEVICES ARE EXPECTED TO DRIVE THE NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030 41
FIGURE 12 THE WEARABLE DEVICE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET FROM 2023 TO 2030 41
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET 57
FIGURE 14 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2022 64
FIGURE 15 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 65
FIGURE 16 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 65
FIGURE 17 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE 66
FIGURE 18 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2022 74
FIGURE 19 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, 2023-2030 (USD MILLION) 75
FIGURE 20 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, CAGR (2023-2030) 75
FIGURE 21 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY TYPE, LIFELINE CURVE 76
FIGURE 22 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, 2022 85
FIGURE 23 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE 2023-2030 (USD MILLION) 86
FIGURE 24 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, CAGR (2023-2030) 86
FIGURE 25 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY PATIENT TYPE, LIFELINE CURVE 87
FIGURE 26 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2022 91
FIGURE 27 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION) 92
FIGURE 28 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, CAGR (2023-2030) 92
FIGURE 29 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY END USER, LIFELINE CURVE 93
FIGURE 30 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022 99
FIGURE 31 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 100
FIGURE 32 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 100
FIGURE 33 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 101
FIGURE 34 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: SNAPSHOT (2022) 107
FIGURE 35 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022) 108
FIGURE 36 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2023 & 2030) 108
FIGURE 37 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: BY COUNTRY (2022 & 2030) 109
FIGURE 38 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: PRODUCT TYPE (2023-2030) 109
FIGURE 39 NORTH AMERICA EPILEPSY MONITORING DEVICES MARKET: COMPANY SHARE 2022 (%) 136